ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Mithra Pharmaceuticals SA

Mithra Pharmaceuticals SA (MITRA)

0.216
0.00
( 0.00% )
Actualizado: 18:00:00

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.216
Postura de Compra
0.20
Postura de Venta
0.0001
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
0.201 Rango de 52 semanas 1.36
Precio Anterior
0.216
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
0.00
Volumen financiero
-
Precio Promedio Ponderado
-

MITRA Últimas noticias

Mithra postpones its annual general meeting

Liege, Belgium, 28 May 2024 – 15:00 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that in the context of the monetization process and the...

Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process

Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent evaluation of several binding offers...

Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023

Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process. As it stands, the aggregate amount of these offers is insufficient to ensure...

Mithra secures court protection measures to advance monetization process

Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing...

Mithra reports full year 2023 financial results

Mithra reports full year 2023 financial results Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from the 2022 result of EUR 67.0 million which was...

Mithra announces changes to its executive management

Mithra announces changes to its executive management Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a...

Mithra initiates monetization process, receives bridge loan from existing lenders

Mithra initiates monetization process, receives bridge loan from existing lenders    Mithra initiates monetization process, receives bridge loan from existing lenders Mithra appoints...

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase           DONESTA® safety study for menopause completes treatment phase...

Mithra sells shares in Mayne Pharma

Mithra sells shares in Mayne Pharma           Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma for EUR ~12.8 millionAs the Mayne Pharma shares...

Mithra updates on cash position

          Mithra updates on cash position Mithra's current cash of EUR 6.5 million is expected to cover its current cash runway through early MarchMithra is actively engaging with...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.2160.2160.21600DE
4000.2160.2160.21600DE
12000.2160.2160.21600DE
26000.2160.2160.21600DE
52-0.974-81.84873949581.191.360.2011205810.55932696DE
156-18.384-98.838709677418.622.10.2011576353.69523618DE
260-26.944-99.20471281327.1628.950.2011213246.98967133DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALNEVNeovacs
0.0002 €
(100.00%)
2.43M
ALEUPEuroplasma
0.05 €
(60.77%)
4.17M
ATOAtos SE
0.81 €
(43.92%)
14.8M
ALGAUGaussin
0.0561 €
(33.57%)
1.63M
TMBSZTME Pharma NV
0.045 €
(32.35%)
160
BIDSGascogne DS
0.0008 €
(-63.64%)
56.03k
EMGDSEuromedis DS
0.0006 €
(-25.00%)
10.64k
ALVETEGEIRO Pharma
0.076 €
(-17.21%)
15.83k
ALACTActicor Biotech
0.25 €
(-13.79%)
17.88k
ALHGRHoffmann Green Cement Technologies
4.01 €
(-9.28%)
12.34k
BCPBanco Comercial Portugues SA
0.4402 €
(-1.08%)
15.64M
ALDRVDrone Volt
0.0036 €
(2.86%)
14.86M
ATOAtos SE
0.81 €
(43.92%)
14.8M
ALEUPEuroplasma
0.05 €
(60.77%)
4.17M
ALTDTonner Drones
0.0096 €
(-5.88%)
3.44M
Bull_Dolphin Bull_Dolphin 6 minutos hace
Finally:

https://revolver.news/2024/11/congress-just-put-ashli-babbit-killer-on-notice/

Well, it seems that Byrd is back in the crosshairs, and this time, he won’t have the Biden regime’s DOJ to protect him.

Investigative reporter Paul Sperry shared an up
Edward Edward 7 minutos hace
Absolutly amazing some are still thinking VXIT is a viable company.

Doesn't surprise me though, sub penny investors never ever sell even when it is clear the company is a Scam or will never survive.

In VXIT'S case, The CEO has criminal charges against him, no sales, ins
VXIT
sab63090 sab63090 7 minutos hace
Hopefully the company will consider using a good Investment Banking Team with some major players (MS, GS, JPM) to come up with some ways to do what is necessary; and that Missling even said was required!... I think he said that he can't do this alone.

They might find things like a siz
JPM
wagner wagner 8 minutos hace
I agree looking at the chart,

But this it say he is a criminal?

NB
SkeBallLarry SkeBallLarry 8 minutos hace
" I b'lieve I've got it tamed, @least for the time being " ...
mtsr mtsr 8 minutos hace
To me, this is the worst week for Stocks only because of the holiday most people buying or trading stocks usually or not this week
QBTS
diggitydoodle diggitydoodle 12 minutos hace
Let's see what happens here today. Aside from the last, nearly three years of daily nothing.
GLTA!
RNVA!!$$???????????????????????
RNVA
Bull_Dolphin Bull_Dolphin 12 minutos hace
Good morning Larry. Got that frisky computer under control again?
payupdeadbeat payupdeadbeat 14 minutos hace
Sadly, your constant optimism is old & faded. The sleeping duo is not participating. Maybe La la la Linda is in the Harvard cafeteria. 
DBMM
sab63090 sab63090 15 minutos hace
Hoskuld

I wasn't sure, but that 20 day posting I read about is probably the 2-3 week timeline to acceptance....I got up a while ago and just started catching up on things for today....let's hope we have a much better outcome than RETT was; I was so focused on that!

My
AVXL
Tadaaa Tadaaa 16 minutos hace
We are at the Golden Cross
HBARUSD
Just the facts maam Just the facts maam 17 minutos hace
Roddy, it also doesn't make sense to sell before announcing the drug approvals.

If North's suggestion is correct we may not get an announcement until the last NDA is approved in Q1, if all goes well.
ANIP
timberwolf7 timberwolf7 17 minutos hace
Got ATNM on my list of 'ones to monitor' cause its not going anywhere for a while.

What a frigging screw job both the company and shareholders just had to deal with.

If nothing else, the fda could have admitted ATNMs development HELPED people
who were dealing wit
ATNM
jeunke22 jeunke22 18 minutos hace
Institutional ownership up by 500k and Shorts down by 180k as of yesterday.
Despite relative weaker position in the Nasdaq index ( LWLG share price down, Nasdaq up) institutions increased their positions from 33.7 mio per 9/30 to 40.3 mio as of yesterday. That’s close to 7 mio shares in 6
LWLG
SkeBallLarry SkeBallLarry 19 minutos hace
" Grreat choice indeed, Bull ~ Good morning " .. !!
Bull_Dolphin Bull_Dolphin 19 minutos hace
Just another lying biotch:

https://www.msn.com/en-us/politics/government/alexandria-ocasio-cortez-says-she-doesn-t-take-lobbyist-cash-records-tell-a-different-story/ar-AA1uO0iy
STILL TOWING STILL TOWING 21 minutos hace
Get ready, The dream team will probably say, Ward woulda pulled off the immaculate storage facility, but Trumps tariff policy blew it.. Now we gotta wait till the next administration.. But hopefully by then, the prominent family backing ward will have been vetted..LOL...You heard it here first. :)
MRGE
Bull_Dolphin Bull_Dolphin 22 minutos hace
Great Choice:

https://redstate.com/bobhoge/2024/11/26/trump-nominates-stanford-professor-who-sounded-alarm-on-covid-lockdownsand-was-censoredfor-dir-of-nih-n2182519
Seminole Red Seminole Red 24 minutos hace
All Russian migrants being denied access to asylum process, says attorney

https://www.msn.com/en-us/news/politics/all-russian-migrants-being-denied-access-to-asylum-process-says-attorney/ar-AA1uMXhl?ocid=msedgntphdr&cvid=428e06a617894bb1e40a5b4dedbbe2f1&ei=309


A
Just the facts maam Just the facts maam 25 minutos hace
That sounds extraordinary to me. It would explain why they never disclosed any info Tezruly and the other two drugs.
ANIP
sab63090 sab63090 25 minutos hace
Tom:
I like your plan and being flexible, too....that's always the best way to look at things, especially after news and potential additional news, we need to adapt, wait, observe and then take our chances...in and out trading forces you to be correct more than your losses & some people can't
AVXL